Group 1 - Company BaiLi TianHeng announced the completion of its new share issuance, with approximately 11.87 million shares issued at a price of 317 yuan per share, raising a total of about 3.764 billion yuan [1] - The newly issued shares are subject to a six-month transfer restriction from the date of issuance [1] - For the year 2024, BaiLi TianHeng's revenue composition is heavily weighted towards the pharmaceutical manufacturing sector, accounting for 99.97% of total revenue, with other businesses contributing only 0.03% [1] Group 2 - As of the latest report, BaiLi TianHeng's market capitalization stands at 149.5 billion yuan [2] - The insurance industry is experiencing significant growth, with a new type of insurance product seeing a 33-fold increase over five years, attracting interest from over 30 insurance companies [2]
百利天恒:发行新增股份约1187万股